MyGenome Institute is a biotechnology company under ALPS Global Holding Berhad (ALPS) specialising in Precision Medicine to provide in-house molecular genomic tests, utilising cutting edge techniques of Next Generation Sequencing (NGS), Digital Gene Platform, Microarray, Real-Time & Standard PCR. Our services include a range of genetic profiles on liquid biopsy to assess the risk of diseases at molecular level for cancers, cardiac and metabolic genetic, neurogenetic , pharmacogenetic, inherited diseases, wellness and fitness related diseases etc.